%0 Journal Article
%T The REFORM study protocol: a cohort randomised controlled trial of a multifaceted podiatry intervention for the prevention of falls in older people
%J BMJ open
%D 2014
%A Cockayne, Sarah
%A Adamson, Joy
%A Corbacho Martin, Belen
%A Fairhurst, Caroline
%A Hewitt, Catherine
%A Hicks, Kate
%A Hull, Robin
%A Keenan, Anne Maree
%A Lamb, Sarah E.
%A Loughrey, Lorraine
%A McIntosh, Caroline
%A Menz, Hylton B.
%A Redmond, Anthony C.
%A Rodgers, Sara
%A Vernon, Wesley
%A Watson, Judith
%A Torgerson, David
%V 4
%N 12
%P e006977-e006977
%X INTRODUCTION: Falls and fall-related injuries are a serious cause of morbidity and cost to society. Foot problems and inappropriate footwear may increase the risk of falls; therefore podiatric interventions may play a role in reducing falls. Two Cochrane systematic reviews identified only one study of a podiatry intervention aimed to reduce falls, which was undertaken in Australia. The REFORM trial aims to evaluate the clinical and cost-effectiveness of a multifaceted podiatry intervention in reducing falls in people aged 65 years and over in a UK and Irish setting. <br><br>METHODS AND ANALYSIS: This multicentre, cohort randomised controlled trial will recruit 2600 participants from routine podiatry clinics in the UK and Ireland to the REFORM cohort. In order to detect a 10% point reduction in falls from 50% to 40%, with 80% power 890 participants will be randomised to receive routine podiatry care and a falls prevention leaflet or routine podiatry care, a falls prevention leaflet and a multifaceted podiatry intervention. The primary outcome is rate of falls (falls/person/time) over 12 months assessed by patient self-report falls diary. Secondary self-report outcome measures include: the proportion of single and multiple fallers and time to first fall over a 12-month period; Short Falls Efficacy Scale-International; fear of falling in the past 4 weeks; Frenchay Activities Index; fracture rate; Geriatric Depression Scale; EuroQoL-five dimensional scale 3-L; health service utilisation at 6 and 12 months. A qualitative study will examine the acceptability of the package of care to participants and podiatrists. ETHICS AND DISSEMINATION: The trial has received a favourable opinion from the East of England-Cambridge East Research Ethics Committee and Galway Research Ethics Committee. The trial results will be published in peer-reviewed journals and at conference presentations. TRIAL REGISTRATION NUMBER: Current Controlled Trials ISRCTN68240461assigned 01/07/2011.<p /> <p>Language: en</p>
%G en
%I BMJ Publishing Group
%@ 2044-6055
%U http://dx.doi.org/10.1136/bmjopen-2014-006977